Editas Medicine (EDIT) Change in Acquisitions & Divestments (2017 - 2025)

Editas Medicine (EDIT) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $40.0 million in Q3 2025.

• On a quarterly basis, Change in Acquisitions & Divestments fell 53.96% year-over-year to $40.0 million in Q3 2025; TTM through Sep 2025 was $170.5 million, a 48.11% decrease from a year earlier, with the FY2024 full-year figure at $257.2 million, down 0.89% from the prior year.
• Change in Acquisitions & Divestments for Q3 2025 stood at $40.0 million, down from $42.5 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for EDIT reached as high as $130.8 million in Q1 2021 and fell as low as $31.5 million in Q4 2024.
• Historically, Change in Acquisitions & Divestments has averaged $76.4 million across 5 years, with a median of $74.2 million in 2021.
• Across the five-year window, Change in Acquisitions & Divestments soared 176.48% in 2021 and tumbled 69.39% in 2024, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $84.3 million in 2021, then declined by 6.91% to $78.5 million in 2022, then jumped by 31.08% to $102.9 million in 2023, then tumbled by 69.39% to $31.5 million in 2024, then grew by 27.03% to $40.0 million in 2025.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $40.0 million in Q3 2025, $42.5 million in Q2 2025, and $56.5 million in Q1 2025.